Has Valerian Fernandes, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,534 in general payments to Valerian Fernandes, MD across 33 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Valerian Fernandes, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Valerian Fernandes, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Valerian Fernandes, MD

Interventional Cardiology · Charleston, SCNPI 1912015967

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $927 of the $1,534 with a category attached, or 60.4%. 9 manufacturers reported payments, led by Novartis at 42.9% of the total. That places this record below the midpoint for interventional cardiology clinicians in SC, where the typical reported total is $8,877.

$1,534in general payments, 2019–2025

Across 33 payments — averaging $46.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$657
Medtronic$294
Acist Medical Systems, Inc.$290
Abbott$92
Cvrx, Inc.$57
Cardiva Medical, Inc.$55
plus $88 from 3 others

$51,481in research payments, 2019–2025

Across 14 payments — averaging $3677.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$44K
Kowa Research Institute, Inc.$7K

What the payments were for

Consulting fees$252%
Travel & lodging$58238%
Food & beverage$92760%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	4	$657
Medtronic	7	$294
Acist Medical Systems, Inc.	9	$290
Abbott	4	$92
Cvrx, Inc.	3	$57
Cardiva Medical, Inc.	2	$55
Boston Scientific	2	$39
Biosense Webster, Inc.	1	$33
Shockwave Medical, Inc	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

LEQVIO$582
COREVALVE EVOLUT R$120

How this compares

$1,534 in reported general payments places this provider in the 5th percentile of 117 interventional cardiology providers in South Carolina.

See all interventional cardiology providers in South Carolina →

Medicare billing

Part B allowed, 2024

$65,863

Medicare patients

292

Services billed

692

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	109	$110,731
XareltoRivaroxaban	17	$19,761
CorlanorIvabradine Hcl	20	$11,700
Metoprolol Succinate	77	$1,187
Rosuvastatin Calcium	48	$831
Ezetimibe	39	$681
Spironolactone	65	$550
Telmisartan-HydrochlorothiazidTelmisartan/Hydrochlorothiazid	12	$424
Nitroglycerin	35	$385
Losartan Potassium	23	$381
Atorvastatin Calcium	49	$370
Isosorbide Mononitrate ErIsosorbide Mononitrate	29	$272
Warfarin Sodium	13	$230
ClopidogrelClopidogrel Bisulfate	29	$197
Metoprolol Tartrate	24	$153

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Charleston

Daniel SteinbergCharleston$611K
Anbukarasi MaranCharleston$132K
Lars RunquistCharleston$54K
Matthew O'SteenCharleston$45K
Scott WoodfieldCharleston$22K
Jeffrey RiederCharleston$14K
Fred KraininCharleston$9K
Brian BrownSpartanburg$389K
Nicholas AmorosoPawleys Island$283K
Robert LeonardiWest Columbia$203K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →